| Primary information |
|---|
| sequence ID | Seq_7225 |
| Peptide sequence | SIQDWVQKTIAEN |
| CancerPDF_ID | CancerPDF_ID6944, CancerPDF_ID9778, |
| PMID | 24982608,21533267 |
| Protein Name | Haptoglobin isoform 2 preproprotein,Haptoglobin |
| UniprotKB Entry Name | HPT_HUMAN,HPT_HUMAN |
| Fluid | Urine,Serum |
| M/Z | NA,766.41 |
| Charge | NA,2 |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | Nano-LC-MS,LC-MS |
| Peptide Identification technique | MS/MS,LC/MS/MS |
| Quantification Technique | NA,Multiple Reaction Monitoring |
| Labelled/Label Free | Label Free,Label Free |
| FDR | 0.01,1.49 |
| CancerPDF_ID | CancerPDF_ID6944, CancerPDF_ID9778, |
| p-Value | NA,NA |
| Software | "GPM search engine, MASCOT",MASCOT |
| Length | 13,13 |
| Cancer Type | Ovarian cancer,Lung adenocarcinoma |
| Database | IPI 3.71 Human Database ,Swissprot Database (57.4) |
| Modification | NA,NA |
| Number of Patients | 6 Ovarian cancer patients and 6 normal individuals,62 lung adenocarcinoma and 30 healthy control |
| Regulation | Uniquely present in case of urine of ovarian cancer patients,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
| Validation | NA,MRM-based validation of 19 candidates |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |